Targeting SHP2 for EGFR inhibitor resistant non-small cell lung carcinoma.

Targeting SHP2 for EGFR inhibitor resistant non-small cell lung carcinoma.
复制标题

DOI:
10.1016/j.bbrc.2013.09.028
复制
发表时间:
2013-10-04
影响因子:
3.1
通讯作者:
Zhang, Zhong-Yin
Zhang, Zhong-Yin
中科院分区:
生物学4区
文献类型:
--
作者:
Xu, Jie;Zeng, Li-Fan;Shen, Weihua;Turchi, John J.;Zhang, Zhong-Yin

文献摘要

参考文献

被引文献

相似文献

Targeted therapy with inhibitors of epidermal growth factor receptor (EGFR) has produced a noticeable benefit to non-small cell lung cancer (NSCLC) patients whose tumors carry activating mutations (e.g. L858R) in EGFR. Unfortunately, these patients develop drug resistance after treatment, due to acquired secondary gatekeeper mutations in EGFR (e.g., T790M). Given the critical role of SHP2 in growth factor receptor signaling, we sought to determine whether targeting SHP2 could have therapeutic value for EGFR inhibitor resistant NSCLC. We show that SHP2 is required for EGF-stimulated ERK1/2 phosphorylation and proliferation in EGFR inhibitor resistant NSCLC cell line H1975, which harbors the EGFR T790M/L858R double-mutant. We demonstrate that treatment of H1975 cells with II-B08, a specific SHP2 inhibitor, phenocopies the observed growth inhibition and reduced ERK1/2 activation seen in cells treated with SHP2 siRNA. Importantly, we also find that II-B08 exhibits marked anti-tumor activity in H1975 xenograft mice. Finally, we observe that combined inhibition of SHP2 and PI3K impairs both the ERK1/2 and PI3K/AKT signaling axes and produces significantly greater effects on repressing H1975 cell growth than inhibition of either protein individually. Collectively, these results suggest that targeting SHP2 may represent an effective strategy for treatment of EGFR inhibitor resistant NSCLCs.
DOI: 10.1056/nejmoa040938
发表时间: 2004-05-20
影响因子: 158.5
作者:
Lynch, TJ;Bell, DW;Haber, DA
通讯作者: Haber, DA
DOI: 10.1182/blood-2003-11-3876
发表时间: 2004-07-15
期刊: BLOOD
影响因子: 20.3
作者:
Tartaglia, M;Martinelli, S;Biondi, A
通讯作者: Biondi, A
DOI: 10.1182/blood-2011-08-375873
发表时间: 2012-09-27
期刊: BLOOD
影响因子: 20.3
作者:
Mali, Raghuveer Singh;Ma, Peilin;Kapur, Reuben
通讯作者: Kapur, Reuben
DOI: 10.1038/sj.onc.1211019
发表时间: 2008-06-05
期刊: ONCOGENE
影响因子: 8
作者:
Miyamoto, D.;Miyamoto, M.;Hatakeyama, M.
通讯作者: Hatakeyama, M.
DOI: 10.1056/nejmoa0810699
发表时间: 2009-09-03
影响因子: 158.5
作者:
Mok, Tony S.;Wu, Yi-Long;Fukuoka, Masahiro
通讯作者: Fukuoka, Masahiro